Prosecution Insights
Last updated: November 04, 2026

Resolve Bio Sciences GmbH

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Resolve Bio Sciences GmbH maintains 1 pending office action located within the Biotechnology & Pharmaceuticals technology area. The prosecution activity is limited to 1 distinct examiner and 1 distinct art unit, which reflects a narrow point of contact with the patent office. This concentration means that the company's current patent outcomes are subject to the interpretation of a single administrative unit. Such a focused portfolio allows for a specialized prosecution strategy but provides no internal baseline for comparing examiner behavior across the company's filings.

The busiest examiner identified in the data is BELLAH, JEFFREY LAWRENCE, who is currently processing 1 pending office action. As this examiner manages the only active action for the portfolio, their individual examination style will dictate the immediate trajectory of the company's intellectual property in the Biotechnology & Pharmaceuticals sector. Practitioners should focus on the specific history of this 1 distinct examiner to navigate the current administrative requirements. The reliance on 1 distinct art unit further emphasizes the need for a targeted approach to the current administrative requirements.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BELLAH, JEFFREY LAWRENCE 1 66.7% +100.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18344324 HIGH RESOLUTION MULTIPLEX METHOD FOR DETECTING AT LEAST TWO TARGETS WITH A DISTANCE OF BEYOND THE DIFFRACTION LIMIT IN A SAMPLE BELLAH, JEFFREY LAWRENCE 50d overdue

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18344324 HIGH RESOLUTION MULTIPLEX METHOD FOR DETECTING AT LEAST TWO TARGETS WITH A DISTANCE OF BEYOND THE DIFFRACTION LIMIT IN A SAMPLE BELLAH, JEFFREY LAWRENCE 50d overdue

Top Art Units

Art UnitApps
1683 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18344324 HIGH RESOLUTION MULTIPLEX METHOD FOR DETECTING AT LEAST TWO TARGETS WITH A DISTANCE OF BEYOND THE DIFFRACTION LIMIT IN A SAMPLE BELLAH, JEFFREY LAWRENCE 1683 §103§112Other Final Rejection 50d overdue Pending Jun 29, 2023

Managing Resolve Bio Sciences GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Resolve Bio Sciences GmbH have?

Resolve Bio Sciences GmbH has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Resolve Bio Sciences GmbH applications?

Jeffrey Lawrence Bellah has the most, with 1 of Resolve Bio Sciences GmbH's pending office actions.

What technology area are Resolve Bio Sciences GmbH's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month